Pauls Dietrich John 4
4 · DiaMedica Therapeutics Inc. · Filed Dec 11, 2018
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Purchase
Voting Common Shares, no par value per share
2018-12-11$4.00/sh+5,000$20,000→ 29,804 total
Footnotes (1)
- [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.